Author: Alistair Mukondiwa

Prescription Label Layouts: Why Your Medication Bottle Looks Different

Prescription labels in the U.S. vary by state, pharmacy, and software system - creating confusion and risking medication errors. Learn why your bottle looks different and how to stay safe.

12.03.26
Alistair Mukondiwa
11

Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers

The FDA uses Import Alerts to block drugs from non-compliant manufacturers before they reach U.S. patients. Learn how the Green List system works, why shipments get detained, and what it means for global drug supply chains.

10.03.26
Alistair Mukondiwa
11

European Generic Markets: How Regulatory Approaches Across the EU Shape Drug Access and Competition

The EU's generic drug approval system is complex, with four different pathways, each affecting how quickly and where a generic reaches patients. The 2025 reforms have changed data protection, launch timelines, and supply rules-shifting how manufacturers enter the market.

6.03.26
Alistair Mukondiwa
12

How to Communicate Past Drug Reactions Before Surgery

Knowing how to clearly communicate past drug reactions before surgery can prevent life-threatening complications. Learn what counts as a true allergy, who needs to know, and how to ensure your history is properly documented for safe anesthesia.

5.03.26
Alistair Mukondiwa
13

Obesity as a Chronic Disease: Understanding Metabolic Health and Realistic Weight Strategies

Obesity is a chronic disease driven by biology, not choice. Learn how metabolic dysfunction, genetics, and modern treatments like GLP-1 agonists are changing how we manage weight - and why willpower alone doesn't work.

3.03.26
Alistair Mukondiwa
0

Packaging and Labeling: How to Verify the Authenticity of Generic Medicines

Learn how to spot fake generic medicines by checking packaging, using UV lights, scanning barcodes, and recognizing subtle differences. Real-world tips from pharmacists and experts to protect your health.

27.02.26
Alistair Mukondiwa
0

Generics vs Brand Biologics: How Much Do They Really Cost?

Biosimilars cut the cost of biologic drugs by over 50% on average, yet most patients still pay full price. Learn why the savings are real, why adoption is slow, and how you can access lower-cost alternatives.

26.02.26
Alistair Mukondiwa
0

RSV Infections: Risks for Infants, Older Adults, and How to Prevent Them

RSV is the leading cause of hospitalization in infants and a major threat to older adults. Learn the real risks, how it spreads, and the new vaccines and preventions that are changing outcomes.

24.02.26
Alistair Mukondiwa
15

Using Copay Cards Safely: Access Without Compromising Care

Copay cards help patients afford expensive medications-but hidden insurer policies like accumulator programs can leave you owing thousands when the card runs out. Learn how to protect your treatment and avoid dangerous financial surprises.

17.02.26
Alistair Mukondiwa
11

How to Appeal Insurance Denials for Brand-Name Medications

Learn how to successfully appeal insurance denials for brand-name medications with step-by-step guidance, real-world examples, and key documentation tips to get your prescription covered.

13.02.26
Alistair Mukondiwa
10

Author: Alistair Mukondiwa - Page 2